Fda Strips Breast Cancer Warning From Menopause Hormone Therapy

The FDA has removed a breast cancer warning from menopause hormone therapy labels, sparking potential debate about the decision's implications; however, the lack of comments suggests a muted discussion.

Snapshot generated from the HN discussion